CX Institutional’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Buy |
1,033
+949
| +1,130% | +$26.6K | ﹤0.01% | 924 |
|
|
2025
Q1 | $2K | Buy |
+84
| New | +$2K | ﹤0.01% | 1144 |
|
|
2024
Q3 | – | Sell |
-4,437
| Closed | -$527K | – | 587 |
|
|
2024
Q2 | $527K | Buy |
4,437
+1,471
| +50% | +$175K | 0.02% | 364 |
|
|
2024
Q1 | $316K | Buy |
2,966
+591
| +25% | +$63K | 0.02% | 442 |
|
|
2023
Q4 | $236K | Buy |
+2,375
| New | +$236K | 0.01% | 458 |
|
|
2023
Q2 | – | Sell |
-2,234
| Closed | -$352K | – | 526 |
|
|
2023
Q1 | $352K | Buy |
2,234
+997
| +81% | +$157K | 0.02% | 392 |
|
|
2022
Q4 | $222K | Buy |
+1,237
| New | +$222K | 0.01% | 481 |
|
|
2022
Q3 | – | Sell |
-61
| Closed | -$9K | – | 889 |
|
|
2022
Q2 | $9K | Buy |
+61
| New | +$9K | ﹤0.01% | 965 |
|
|
2021
Q4 | – | Sell |
-13
| Closed | -$5K | – | 711 |
|
|
2021
Q3 | $5K | Buy |
+13
| New | +$5K | ﹤0.01% | 866 |
|